Evidence map›Paper›PMID 28542600›Full record

ArticlePloS one2017

SNP in human ARHGEF3 promoter is associated with DNase hypersensitivity, transcript level and platelet function, and Arhgef3 KO mice have increased mean platelet volume.

Siying Zou, Alexandra M Teixeira, Myrto Kostadima, William J Astle, Aparna Radhakrishnan, Lukas Mikolaj Simon, Lucy Truman, Jennifer S Fang, John Hwa, Ping-Xia Zhang and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. ARHGEF3 Regulates Hair Follicle Morphogenesis.bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Analysis of genetic dominance in the UK Biobank.Science (New York, N.Y.) · 2023
    Article
  12. Article
  13. Article
  14. Role of ARHGEF3 as a GEF and mTORC2 Regulator.Frontiers in cell and developmental biology · 2021
    Review
  15. Article
  16. Arhgef1 Plays a Vital Role in Platelet Function and Thrombogenesis.Journal of the American Heart Association · 2019
    Article
  17. Article
  18. SelectedClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Siying ZouDepartment of Cell Biology, Yale School of Medicine, New Haven, Connecticut, United States of America.
Alexandra M TeixeiraDepartment of Pathology, Yale School of Medicine, New Haven, Connecticut, United States of America.
Myrto KostadimaDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
William J AstleDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Aparna RadhakrishnanDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Lukas Mikolaj SimonDepartment of Structural and Computational Biology, Baylor College of Medicine, Houston, TX, United States of America.
Lucy TrumanDepartment of ENT, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Jennifer S FangYale Cardiovascular Research Center, Department of Cardiology, Yale University School of Medicine, New Haven, CT, United States of America.
John HwaYale Cardiovascular Research Center, Department of Cardiology, Yale University School of Medicine, New Haven, CT, United States of America.
Ping-Xia ZhangDepartment of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.
Pim van der HarstUniversity of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.
Paul F BrayDepartment of Medicine and the Program in Molecular Medicine, University of Utah, Salt Lake City, Utah, United States of America.
Willem H OuwehandDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Mattia FrontiniDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Diane S KrauseDepartment of Cell Biology, Yale School of Medicine, New Haven, Connecticut, United States of America.ORCID http://orcid.org/0000-0001-9420-6947
University of Cambridge · GBYale University · USYale Cancer Center · USAddenbrooke's Hospital · GBBaylor College of Medicine · USUniversity Medical Center Groningen · NLUniversity of Utah · US

Funding

Yale Cooperative Hematology Specialized Core CenterU54DK106857 · NIDDK · YALE UNIVERSITY · PI JOHN HWA, Diane S Krause · 2015 to 2026
$9.7M
Yale Center of Excellence in Molecular HematologyP30DK072442 · NIDDK · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2005 to 2010
$5.2M
Variation in platelet function: the genetics of platelet gene expressionR01HL102482 · NHLBI · UNIVERSITY OF UTAH · PI BRAY, PAUL F. · 2010 to 2018
$4.6M
Hyperglycemia, thromboxane and platelet activity in diabetes mellitusR01HL115247 · NHLBI · YALE UNIVERSITY · PI HWA, JOHN · 2012 to 2019
$3.8M
Platelet Mitochondrial Function in Health and DiseaseR01HL122815 · NHLBI · YALE UNIVERSITY · PI HWA, JOHN · 2015 to 2023
$3.7M
Mechanisms of megakaryocyte maturationR01DK094934 · NIDDK · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2012 to 2016
$2.7M
MKL in megakaryocytopoiesisR01DK086267 · NIDDK · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2010 to 2013
$1.5M
British Heart Foundation RE/13/6/30180British Heart Foundation RG/08/014/24067Department of Health RP-PG-0310-1002Medical Research Council MR/L003120/1NHLBI NIH HHS R01 HL102482NHLBI NIH HHS R01 HL115247NHLBI NIH HHS R01 HL122815NIDDK NIH HHS P30 DK072442NIDDK NIH HHS R01 DK086267NIDDK NIH HHS R01 DK094934NIDDK NIH HHS U54 DK106857
6 · The paper itself

Abstract

Genome-wide association studies have identified a genetic variant at 3p14.3 (SNP rs1354034) that strongly associates with platelet number and mean platelet volume in humans. While originally proposed to be intronic, analysis of mRNA expression in primary human hematopoietic subpopulations reveals that this SNP is located directly upstream of the predominantly expressed ARHGEF3 isoform in megakaryocytes (MK). We found that ARHGEF3, which encodes a Rho guanine exchange factor, is dramatically upregulated during both human and murine MK maturation. We show that the SNP (rs1354034) is located in a DNase I hypersensitive region in human MKs and is an expression quantitative locus (eQTL) associated with ARHGEF3 expression level in human platelets, suggesting that it may be the causal SNP that accounts for the variations observed in human platelet traits and ARHGEF3 expression. In vitro human platelet activation assays revealed that rs1354034 is highly correlated with human platelet activation by ADP. In order to test whether ARHGEF3 plays a role in MK development and/or platelet function, we developed an Arhgef3 KO/LacZ reporter mouse model. Reflecting changes in gene expression, LacZ expression increases during MK maturation in these mice. Although Arhgef3 KO mice have significantly larger platelets, loss of Arhgef3 does not affect baseline MK or platelets nor does it affect platelet function or platelet recovery in response to antibody-mediated platelet depletion compared to littermate controls. In summary, our data suggest that modulation of ARHGEF3 gene expression in humans with a promoter-localized SNP plays a role in human MKs and human platelet function-a finding resulting from the biological follow-up of human genetic studies. Arhgef3 KO mice partially recapitulate the human phenotype.

Indexed as

Polymorphism, Single NucleotideAnimalsBlood PlateletsCell DifferentiationCell SizeCohort StudiesFemaleFetal BloodGene Expression RegulationHumansMaleMean Platelet VolumeMegakaryocytesMice, Inbred C57BLMice, KnockoutPromoter Regions, GeneticARHGEF3 protein, humanARHGEF3 protein, mouseRho Guanine Nucleotide Exchange Factors

Identifiers

PMID28542600
PMCPMC5441597
OpenAlexW2617039577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.